The Ets family contains transcriptional activators and repressors involved in angiogenesis.
暂无分享,去创建一个
B. Vandenbunder | F. Soncin | E Lelièvre | B Vandenbunder | F Lionneton | F Soncin | E. Lelièvre | F. Lionneton
[1] P. Seeburg,et al. Tripartite structure of the avian erythroblastosis virus E26 transforming gene , 1983, Nature.
[2] P. Ingham,et al. Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos , 2000, Mechanisms of Development.
[3] D. Watson,et al. Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter , 1999, Oncogene.
[4] C. Egles,et al. Expression of the c-ets1 gene in the hypothalamus and pituitary during rat development. , 1996, Brain research. Developmental brain research.
[5] Jha,et al. Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin. , 1999, Angewandte Chemie.
[6] M. Abe,et al. ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.
[7] I. Kola,et al. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products , 1999, Cell Death and Differentiation.
[8] D. Stéhelin,et al. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. , 1996, Oncogene.
[9] T. Graf,et al. MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation , 1996, Cell.
[10] J. Ghysdael,et al. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. , 1994, The Journal of biological chemistry.
[11] P. Verde,et al. A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. , 1992, The EMBO journal.
[12] F. Senan,et al. Overexpression of the Xenopus Xl-fli gene during early embryogenesis leads to anomalies in head and heart development and erythroid differentiation. , 1996, The International journal of developmental biology.
[13] Bonnie F. Sloane,et al. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. , 2000, DNA and cell biology.
[14] J. Ghysdael,et al. The ETS Family of Transcriptional Regulators , 1997 .
[15] E. Brambilla,et al. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[16] M. Abe,et al. Ets‐1 regulates angiogenesis by inducing the expression of urokinase‐type plasminogen activator and matrix metalloproteinase‐1 and the migration of vascular endothelial cells , 1996, Journal of cellular physiology.
[17] L. Pardanaud,et al. Expression of C-ETS1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. , 1993, Cell adhesion and communication.
[18] C. Hänni,et al. Molecular phylogeny of the ETS gene family , 1999, Oncogene.
[19] D. Cohen,et al. Hypotonicity activates transcription through ERK-dependent and -independent pathways in renal cells. , 1998, American journal of physiology. Cell physiology.
[20] D. Luton,et al. The c-ets1 protooncogene is expressed in human trophoblast during the first trimester of pregnancy. , 1997, Early human development.
[21] T. Gu,et al. Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor α2 , 2000, Molecular and Cellular Biology.
[22] Y. De Launoit,et al. Requirement of a GT Box (Sp1 Site) and Two Ets Binding Sites for Vascular Endothelial Cadherin Gene Transcription* , 1998, The Journal of Biological Chemistry.
[23] A. Seth,et al. ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] O. Volpert,et al. Maspin is an angiogenesis inhibitor , 2000, Nature Medicine.
[25] N. Janel,et al. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene , 1997, Oncogene.
[26] Michael C. Ostrowski,et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2 , 1996, Molecular and cellular biology.
[27] Runzhao Li,et al. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes , 2000, Oncogene.
[28] J. Baert,et al. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors , 1998, Oncogene.
[29] F. Dewitte,et al. Mesodermal expression of the chicken erg gene associated with precartilaginous condensation and cartilage differentiation , 1995, Mechanisms of Development.
[30] B. Wasylyk,et al. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.
[31] F. Breviario,et al. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. , 1996, Blood.
[32] M. Edel. The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-cells. , 1998, Anticancer Research.
[33] H. Orzechowski,et al. Endothelial expression of endothelin-converting enzyme-1 beta mRNA is regulated by the transcription factor Ets-1. , 1998, Journal of cardiovascular pharmacology.
[34] A. Seth,et al. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. , 1993, Oncogene.
[35] B. Graves,et al. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. , 2000, Genes & development.
[36] K. Murakami,et al. c-Ets-1 protein is hyperphosphorylated during mitosis. , 1993, Oncogene.
[37] M. Shibuya,et al. Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor. , 1996, Growth factors.
[39] B. Wasylyk,et al. The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.
[40] P. Defossez,et al. Differential expression patterns of the PEA3 group transcription factors through murine embryonic development , 1997, Oncogene.
[41] D. Bonthron,et al. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells. , 1994, The Journal of biological chemistry.
[42] B. Wasylyk,et al. Reversion of Ras transformed cells by Ets transdominant mutants. , 1994, Oncogene.
[43] K. Alitalo,et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. , 1995, Blood.
[44] M. Rivera,et al. A Role for CREB Binding Protein and p300 Transcriptional Coactivators in Ets-1 Transactivation Functions , 1998, Molecular and Cellular Biology.
[45] J. Lautenberger,et al. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. , 1997, Cancer research.
[46] J. Hassell,et al. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase , 1998, Oncogene.
[47] A. Bernstein,et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes , 1995, Molecular and cellular biology.
[48] P. Oettgen,et al. Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] B. Vandenbunder,et al. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. , 1989, Development.
[50] K. Tanaka,et al. Induction of Ets‐1 in endothelial cells during reendothelialization after denuding injury , 1998, Journal of cellular physiology.
[51] S. Tsai,et al. The ets Family Member Tel Binds to the Fli-1 Oncoprotein and Inhibits Its Transcriptional Activity* , 1998, The Journal of Biological Chemistry.
[52] Masahiro Ito,et al. Expression of Ets-1 transcription factor in relation to angiogenesis in the healing process of gastric ulcer. , 1998, Biochemical and biophysical research communications.
[53] The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. , 1999 .
[54] T. Imanishi,et al. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression. , 1998, European journal of biochemistry.
[55] L. Williams,et al. A Novel Promoter for Vascular Endothelial Growth Factor Receptor (flt-1) That Confers Endothelial-specific Gene Expression (*) , 1995, The Journal of Biological Chemistry.
[56] D. Landsman,et al. Common sequence and structural features in the heat-shock factor and Ets families of DNA-binding domains. , 1995, Trends in biochemical sciences.
[57] D. Stéhelin,et al. The Ets Transcription Factors Interact with Each Other and with the c-Fos/c-Jun Complex via Distinct Protein Domains in a DNA-dependent and -independent Manner* , 1997, The Journal of Biological Chemistry.
[58] Joshua R. Smith,et al. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. , 1998, Blood.
[59] B. Vandenbunder,et al. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.
[60] D. Leprince,et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26 , 1983, Nature.
[61] T. Alber,et al. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. , 1995, Science.
[62] Yang Wang,et al. Characterization of the Human Endothelial Nitric-oxide Synthase Promoter* , 1999, The Journal of Biological Chemistry.
[63] J. Rossant,et al. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. , 1995, The EMBO journal.
[64] M. Roussel,et al. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. , 1994, Oncogene.
[65] A. Seth,et al. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. , 1990, Oncogene.
[66] R. J. Fisher,et al. An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. , 1994, The Journal of biological chemistry.
[67] B. Graves,et al. Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. , 1990, Genes & development.
[68] M. Shibuya,et al. A cAMP Response Element and an Ets Motif Are Involved in the Transcriptional Regulation of flt-1 Tyrosine Kinase (Vascular Endothelial Growth Factor Receptor 1) Gene* , 1996, The Journal of Biological Chemistry.
[69] Thomas N. Sato,et al. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. , 1999, Circulation research.
[70] T. Veikkola,et al. Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.
[71] O. Bernard,et al. TEL Is a Sequence-specific Transcriptional Repressor* , 1999, The Journal of Biological Chemistry.
[72] J. Fagin,et al. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.
[73] A. Seth,et al. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. , 1996, Oncogene.
[74] Thomas N. Sato,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.
[75] B. Vandenbunder,et al. Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. , 1993, The International journal of developmental biology.
[76] Thomas N. Sato,et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[77] N. Abraham,et al. Upregulation of human heme oxygenase gene expression by Ets‐family proteins , 1999, Journal of cellular biochemistry.
[78] M. Stella,et al. Ets up-regulates MET transcription. , 1996, Oncogene.
[79] B. Vandenbunder,et al. Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures , 2000, Oncogene.
[80] M. Tymms,et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[81] N Muthusamy,et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.
[82] R. J. Fisher,et al. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets‐associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. , 1995, The EMBO journal.
[83] M. Yaniv,et al. Oncogenes as Transcriptional Regulators , 1997, Progress in Gene Expression.
[84] B. Vandenbunder,et al. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin , 2000, Oncogene.
[85] N. Bhat,et al. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. , 1990, Oncogene.
[86] D. Leprince,et al. p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo. , 1993, Oncogene.
[87] P. Stiegler,et al. The avian fli gene is specifically expressed during embryogenesis in a subset of neural crest cells giving rise to mesenchyme. , 1998, The International journal of developmental biology.
[88] C. Albanese,et al. Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.
[89] E. Rothenberg,et al. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. , 1999, Development.
[90] Z. Werb,et al. Synergistic Transcriptional Activation of the Tissue Inhibitor of Metalloproteinases-1 Promoter via Functional Interaction of AP-1 and Ets-1 Transcription Factors (*) , 1996, The Journal of Biological Chemistry.
[91] D. Dhar,et al. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma. , 1998, Journal of hepatology.
[92] P. Libby,et al. Small Mechanical Strains Selectively Suppress Matrix Metalloproteinase-1 Expression by Human Vascular Smooth Muscle Cells* , 1998, Journal of Biological Chemistry.
[93] K. Tanaka,et al. Angiogenesis inhibition by transdominant mutant Ets‐1 , 2000, Journal of cellular physiology.
[94] A. Bernstein,et al. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia , 1996, Molecular and cellular biology.
[95] B. Vandenbunder,et al. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. , 1996, The International journal of developmental biology.
[96] D. Watson,et al. Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.
[97] Y. Fujiwara,et al. Vascular endothelial cell lineage-specific promoter in transgenic mice. , 1995, Development.
[98] A. Albor,et al. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor , 1999, Oncogene.
[99] A. Malik,et al. H2O2 and Tumor Necrosis Factor-α Activate Intercellular Adhesion Molecule 1 (ICAM-1) Gene Transcription through Distinct cis-Regulatory Elements within the ICAM-1 Promoter (*) , 1995, The Journal of Biological Chemistry.
[100] S. Naito,et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. , 1998, Life sciences.
[101] T. Golub,et al. Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL , 1997, The EMBO journal.
[102] S. Weitzman,et al. p300/cAMP-responsive Element-binding Protein Interactions with Ets-1 and Ets-2 in the Transcriptional Activation of the Human Stromelysin Promoter* , 1999, The Journal of Biological Chemistry.
[103] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[104] S. Gory-Fauré,et al. Role of vascular endothelial-cadherin in vascular morphogenesis. , 1999, Development.
[105] P. Coffer,et al. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. , 1994, Oncogene.
[106] B. Vandenbunder,et al. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. , 1992, The American journal of pathology.
[107] O. Farokhzad,et al. The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements , 1994, Molecular and cellular biology.
[108] B. Vandenbunder,et al. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[109] P. Remy,et al. Xl erg: Expression pattern and overexpression during development plead for a role in endothelial cell differentiation , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.
[110] V. Gouyer,et al. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. , 1995, The American journal of pathology.
[111] S. Orkin,et al. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. , 2000, Blood.
[112] O. Wiestler,et al. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. , 1999, Cancer research.
[113] M. Kurkinen,et al. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. , 1993, The Journal of biological chemistry.
[114] R. Treisman,et al. Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.